Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2020-02-14
06:11 am
Purchase		13GEnlivex Therapeutics Ltd.
ENLV		Nussbaum Ran68,580
0.7%		68,580increase
(New Position)		View
2019-09-09
4:08 pm
Sale		13GEnlivex Therapeutics Ltd.
ENLV		Hobi Michael498,432
4.93%		-192,878decrease
(-27.90%)		View
2019-06-27
3:10 pm
Purchase		13GEnlivex Therapeutics Ltd.
ENLV		HBL- HADASIT BIO-HOLDINGS LTD.1,798,727
17.79%		1,798,727increase
(New Position)		View
2019-06-26
12:16 pm
Purchase		13GEnlivex Therapeutics Ltd.
ENLV		Kretzmer & Associates PLLC830,973
8.22%		830,973increase
(New Position)		View
2019-06-26
10:52 am
Purchase		13GEnlivex Therapeutics Ltd.
ENLV		KIP Global Pharma-Ecosystem Private Equity Fund1,417,950
14.02%		1,417,950increase
(New Position)		View
2019-06-19
3:07 pm
Purchase		13GEnlivex Therapeutics Ltd.
ENLV		Hobi Michael691,310
6.84%		691,310increase
(New Position)		View
2019-05-31
12:17 pm
Purchase		13DEnlivex Therapeutics Ltd.
ENLV		NOVIK SHAI A882,515
8.6%		882,515increase
(New Position)		View
2019-02-14
10:20 am
Sale		13GEnlivex Therapeutics Ltd.
ENLV		Nussbaum Ran505,802
15.1%		-2,250decrease
(-0.44%)		View
2019-02-14
06:10 am
Sale		13GEnlivex Therapeutics Ltd.
ENLV		Gilboa Udi0
0%		-468,700decrease
(Position Closed)		View